Electromedical Technologies (Electromedical Technologies) Debt-to-Equity : -0.59 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Electromedical Technologies Debt-to-Equity?

Electromedical Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1.44 Mil. Electromedical Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.26 Mil. Electromedical Technologies's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-2.87 Mil. Electromedical Technologies's debt to equity for the quarter that ended in Dec. 2023 was -0.59.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Electromedical Technologies's Debt-to-Equity or its related term are showing as below:

EMED' s Debt-to-Equity Range Over the Past 10 Years
Min: -2.17 Med: -1.04 Max: -0.59
Current: -0.59

During the past 5 years, the highest Debt-to-Equity Ratio of Electromedical Technologies was -0.59. The lowest was -2.17. And the median was -1.04.

EMED's Debt-to-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.21 vs EMED: -0.59

Electromedical Technologies Debt-to-Equity Historical Data

The historical data trend for Electromedical Technologies's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Electromedical Technologies Debt-to-Equity Chart

Electromedical Technologies Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

-1.13

-1.04

-2.17

-0.89

-0.59

Electromedical Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial														-0.89	-1.47	-0.69	-0.68	-0.59

Competitive Comparison of Electromedical Technologies's Debt-to-Equity

For the Medical Devices subindustry, Electromedical Technologies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Electromedical Technologies's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Electromedical Technologies's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Electromedical Technologies's Debt-to-Equity falls into.

Electromedical Technologies Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Electromedical Technologies's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.442	+	0.256)	/	-2.873
	=	-0.59

Electromedical Technologies's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.442	+	0.256)	/	-2.873
	=	-0.59

Electromedical Technologies (OTCPK:EMED) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Electromedical Technologies Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Electromedical Technologies's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Electromedical Technologies (Electromedical Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Electromedical Technologies Inc (OTCPK:EMED) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

16561 North 92nd Street, Suite 101, Scottsdale, AZ, USA, 85260

Website

https://www.electromedtech.com

Electromedical Technologies Inc is a bioelectronics manufacturing company. It designs and develops simple-to-use bioelectronics therapy devices, which in major cases provide immediate and long-lasting pain relief across the broadest range of ailments. Its focuses on improving global wellness for people suffering from various painful conditions. It Develops and manufactures bioelectronics products.

Executives

Hymers Iii R. Leslie	director	520 S GRAND AVENUE, STE 320, LOS ANGELES CA 90071
Lee Benson	director	PO BOX 41828, MESA AZ 41828
Donald J Steinberg	10 percent owner	3223 SUMAC ROAD, FALLBROOK CA 92028
Matthew Wolfson	director, officer: CEO, CFO	16561 N. 92ND STREET, STE. 101, SCOTTSDALE AZ 85260